Device attributes
Additional documents
Active ingredients
Indications
Dosage
Prescribing info
Device attributes
Additional documents
Active ingredients
Each vial contains delafloxacin meglumine equivalent to 300 mg delafloxacin. After reconstitution each ml contains 25 mg of delafloxacin. Each tablet contains delafloxacin meglumine equivalent to 450 mg delafloxacin.
Indications
Quofenix is   indicated for the treatment of the following infections in adults:•acute bacterial skin and skin structure infections (ABSSSI) •community-acquired pneumonia (CAP)when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4.4 and 5.1).Consideration should be given to official guidance on the appropriate use of antibacterial agents
Dosage
The recommended dose is 300 mg delafloxacin every 12 hours administered over 60 minutes by intravenous infusion. Switch to delafloxacin 450 mg tablet orally every 12 hours is possible at the discretion of the physician. The total duration of treatment is 5 to 14 daysfor ABSSSI and 5 to 10 days for CAP. The recommended regimen of delafloxacin is 450 mg oral every 12 hours for a total duration of 5 to 14 days for ABSSSI and 5 to 10 days for CAP at the discretion of the physician. Delafloxacin tablets can be taken with or without food
Prescribing info
